CIK 0001807983 · Non-accelerated filer<br>Emerging growth company
Medicenna Therapeutics Corp.
Sign in to watch- Ticker
- MDNAF
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Canada (Federal Level)
- Entity type
- other
- Phone
- 403-613-1453
- Business address
- 2 BLOOR STREET W., SUITE 903, TORONTO, Ontario, Canada
- D Other Notice of Sales of Unregistered Securities
- 15-12G Other 15-12G
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- POS AM Other Post-effective Amendment for Registration Statement
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- AW Other AW
- S-8 POS Other Post-effective Amendment
- F-3/A Offering F-3/A
- F-10POS Other F-10POS
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 1 of 9 · 178 filings